» Articles » PMID: 32749005

Power and Purchasing: Why Strategic Purchasing Fails

Overview
Journal Milbank Q
Date 2020 Aug 5
PMID 32749005
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Strategic purchasing of health care has been a popular policy idea around the world for decades, with advocates claiming that it can lead to improved quality, patient satisfaction, efficiency, accountability, and even population health. In this article, we report the results of an inquiry into the implementation and effects of strategic purchasing.

Methods: We conducted three in-depth case studies of England, the Netherlands, and the United States. We reviewed definitions of purchasing, including its slow acquisition of adjectives such as strategic, and settled on a definition of purchasing that distinguishes it from the mere use of contracts to regulate stable interorganizational relationships. The case studies review the career of strategic purchasing in three different systems where its installation and use have been a policy priority for years.

Findings: No existing health care system has effective strategic purchasing because of four key asymmetries: market power asymmetry, information asymmetry, financial asymmetry, and political power asymmetry.

Conclusions: Further investment in policies that are premised on the effectiveness of strategic purchasing, or efforts to promote it, may not be worthwhile. Instead, policymakers may need to focus on the real sources of power in a health care system. Policy for systems with existing purchasing relationships should take into account the asymmetries, ways to work with them, and the constraints that they create.

Citing Articles

Measuring Active Purchasing in Healthcare: Analysing Reallocations of Funds Between Providers to Evaluate Purchasing Systems Performance in the Netherlands.

Stadhouders N, Koolman X, Tanke M, Maarse H, Jeurissen P Int J Health Policy Manag. 2024; 12:7506.

PMID: 38618807 PMC: 10590252. DOI: 10.34172/ijhpm.2023.7506.


How to become a strategic purchaser of rehabilitation services.

Chikhradze T, Brainerd E, Ishtiaq A, Alperson R Bull World Health Organ. 2022; 100(11):709-716.

PMID: 36324546 PMC: 9589378. DOI: 10.2471/BLT.21.287499.


Exploring the roles of players in strategic purchasing for healthcare in Africa-a scoping review.

Kachapila M, Kigozi J, Oppong R Health Policy Plan. 2022; 38(1):97-108.

PMID: 36318330 PMC: 9849715. DOI: 10.1093/heapol/czac093.


Strategic purchasing and health systems resilience: Lessons from COVID-19 in selected European countries.

Montas M, Klasa K, van Ginneken E, Greer S Health Policy. 2022; 126(9):853-864.

PMID: 35773063 PMC: 9195347. DOI: 10.1016/j.healthpol.2022.06.005.


Can the Profitability of Medical Enterprises Be Improved After Joining China's Centralized Drug Procurement? A Difference-in-Difference Design.

Hua Y, Lu J, Bai B, Zhao H Front Public Health. 2022; 9:809453.

PMID: 35178375 PMC: 8843945. DOI: 10.3389/fpubh.2021.809453.

References
1.
Maarse H, Paulus A . The politics of health-care reform in the Netherlands since 2006. Health Econ Policy Law. 2011; 6(1):125-34. DOI: 10.1017/S174413311000037X. View

2.
Gray B, Gusmano M, Collins S . AHCPR and the changing politics of health services research. Health Aff (Millwood). 2003; Suppl Web Exclusives:W3-283-307. DOI: 10.1377/hlthaff.w3.283. View

3.
Marmor T, Oberlander J . From HMOs to ACOs: the quest for the Holy Grail in U.S. health policy. J Gen Intern Med. 2012; 27(9):1215-8. PMC: 3514994. DOI: 10.1007/s11606-012-2024-6. View

4.
Chevreul K, Brigham K, Durand-Zaleski I, Hernandez-Quevedo C . France: Health System Review. Health Syst Transit. 2016; 17(3):1-218, xvii. View

5.
Schut F, Varkevisser M . Competition policy for health care provision in the Netherlands. Health Policy. 2016; 121(2):126-133. DOI: 10.1016/j.healthpol.2016.11.002. View